Long-term follow-up of children treated in Children's Oncology Group cancer studies
Tracks long-term health of children with leukemia or solid tumors after cancer treatment.
Plain-language title generated from the registry record
Registry title: Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Key facts
- Where
- San Juan, Puerto RicoSee the site
Where in Puerto Rico
- San Jorge Children's HospitalSan Juan, Puerto RicoNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Children's Oncology Group
- Trial code
- NCT00736749
- Record updated
- 20 October 2026
- Original description
This clinical trial keeps track of and collects follow-up information from patients who are currently enrolled on or have participated in a Children's Oncology Group study. Developing a way to keep track of patients who have participated in Children's Oncology Group studies may allow doctors learn more about the long-term effects of cancer treatment and help them reduce problems related to treatment and improve patient quality of life.Read full original descriptionShow less
Umbrella Long-Term Follow-Up Protocol
This clinical trial keeps track of and collects follow-up information from patients who are currently enrolled on or have participated in a Children's Oncology Group study. Developing a way to keep track of patients who have participated in Children's Oncology Group studies may allow doctors learn more about the long-term effects of cancer treatment and help them reduce problems related to treatment and improve patient quality of life.
Inclusion: The patient must reside in the U.S. on the date of enrollment to ALTE05N1; All patients and/or their parents or legal guardians must sign a written informed consent; All institutional, Food and Drug Administration (FDA), and National Cancer Institute (NCI) requirements for human studies must be met.